Christopher D. Breder

6.0k citations

37 papers · 4.9k indexed · 3 hit papers · h-index 23

Impact in

Behavioral Neuroscience top 1%
- Stress Responses and Cortisol
Biological Psychiatry top 2%

Papers in

Endocrine and Autonomic Systems 6
- Neuroscience of respiration and sleep 5
Toxicology 3

Co-authors: Clifford B. Saper Charles A. Dinarello David L. DeWitt Richard P. Kraig Kazuki Yasuda Terry Reisine David F. Cechetto Yukihiko Yasui
Journals: The Journal of Comparative Neurology (6 papers)Neurobiology of Aging (3 papers)American Journal of Geriatric Psychiatry (2 papers)European Neuropsychopharmacology (2 papers)Journal of Clinical Psychopharmacology (2 papers)
Partner nations: United States Belgium Japan

In The Last Decade

Christopher D. Breder

37 papers receiving 4.7k citations

Hit Papers

align trajectories log scale

Homer Regulates the Association of Group 1 Metabotropic Glutamate Receptors with Multivalent Complexes of Homer-Related, Synaptic Proteins 1998 · 551 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

1998 Neuron
1993 Proceedings of the National Academy of Sciences
1988 Science

Peers

Countries citing papers authored by Christopher D. Breder

Since Specialization

Citations

This map shows the geographic impact of Christopher D. Breder's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher D. Breder with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher D. Breder more than expected).

Fields of papers citing papers by Christopher D. Breder

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher D. Breder. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher D. Breder. The network helps show where Christopher D. Breder may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Christopher D. Breder, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Christopher D. Breder Line = papers co-authored together Christopher D. Breder links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	PHP343 - CLINICAL DEVELOPMENT OF BIOLOGICS APPROVED BY THE U.S. FOOD AND DRUG ADMINISTRATION, 2003-2016 Value in Health ·G. Caleb Alexander, K. OGASAWARA, Gabriela Aguiar Campolina, M Asvarisch, Christopher D. Breder	2018	1
2	Clinical Development of Biologics Approved by the US Food and Drug Administration, 2003-2016 Therapeutic Innovation & Regulatory Science ·G. Caleb Alexander, K. OGASAWARA, Gabriela Aguiar Campolina, Dora H. Lin, Christopher D. Breder	2018	5
3	Identification of factors associated with first-cycle drug approval rates and regulatory outcomes for new drug applications Pharmacological Research ·Lin‐Chau Chang, Alejandro Benavides Sotomayor, Xiao Fang, Christopher D. Breder	2018	1
4	A Critical Evaluation of Safety Signal Analysis Using Algorithmic Standardised MedDRA Queries Drug Safety ·Youqin Zhang, Christopher D. Breder	2018	22
5	Patterns of use and impact of standardised MedDRA query analyses on the safety evaluation and review of new drug and biologics license applications PLoS ONE ·Lin‐Chau Chang, A. Starchakov, 辻川元一, Christopher D. Breder	2017	12
6	Exposure– and Dose–response Analyses in Dose Selection and Labeling of FDA-approved Biologics Clinical Therapeutics ·K. OGASAWARA, Christopher D. Breder, Dora H. Lin, G. Caleb Alexander	2017	10
7	A Method for Retrieval of Adverse Event Terms in Clinical Trial Databases Using Standardised MedDRA Queries Pharmaceutical Medicine ·Christopher D. Breder	2016	5
8	A Multicenter, Randomized, Double-Blind Study of the Effects of Aripiprazole in Overweight Subjects With Schizophrenia or Schizoaffective Disorder Switched From Olanzapine The Journal of Clinical Psychiatry ·John W. Newcomer, Frank F. Avedo, Ronald N. Marcus, Christopher D. Breder, Robert Berman, W. Kerselaers, Gilbert L’Italien, Marleen Nys, William H. Carson, Robert D. McQuade	2008	96
9	A Randomized, Double-Blind, Placebo-Controlled Study of Aripiprazole for the Treatment of Psychosis in Nursing Home Patients with Alzheimer Disease American Journal of Geriatric Psychiatry ·Joel E. Streim, Anton P. Porsteinsson, Christopher D. Breder, René Swanink, Ronald N. Marcus, Robert D. McQuade, William H. Carson	2008	83
10	Aripiprazole for the Treatment of Psychoses in Institutionalized Patients With Alzheimer Dementia: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Assessment of Three Fixed Doses American Journal of Geriatric Psychiatry ·Jacobo Mintzer, Larry E. Tune, Christopher D. Breder, René Swanink, Ronald N. Marcus, Robert D. McQuade, Andrew Forbes	2007	110
11	Aripiprazole for the Treatment of Psychosis in Patients With Alzheimer's Disease Journal of Clinical Psychopharmacology ·Peter Paul De Deyn, Dilip V. Jeste, René Swanink, Dušan Kostić, Christopher D. Breder, William H. Carson, Taro Iwamoto	2005	112
12	Homer Regulates the Association of Group 1 Metabotropic Glutamate Receptors with Multivalent Complexes of Homer-Related, Synaptic Proteins Neuron ·Bo Xiao, Jian Cheng Tu, Ronald S. Petralia, Joseph P. Yuan, Andrew Doan, Christopher D. Breder, Alicia M. Ruggiero, Anthony A. Lanahan, Robert J. Wenthold, Paul Worley Hit paper breakdown →	1998	551
13	Cyclooxygenase Systems in the Mammalian Brain Annals of the New York Academy of Sciences ·Christopher D. Breder	1997	29
14	Intravenous lipopolysaccharide induces cyclooxygenase 2-like immunoreactivity in rat brain perivascular microglia and meningeal macrophages The Journal of Comparative Neurology ·Joel K. Elmquist, Christopher D. Breder, Jonathan E. Sherin, Thomas E. Scammell, William F. Hickey, David L. DeWitt, Clifford B. Saper	1997	240
15	Long-term elevation of cyclooxygenase-2, but not lipoxygenase, in regions synaptically distant from spreading depression The Journal of Comparative Neurology ·Anthony O. Caggiano, Christopher D. Breder, Richard P. Kraig	1996	46
16	Differential expression of messenger RNAs for somatostatin receptor subtypes SSTR1, SSTR2 and SSTR3 in adult rat brain: Analysis by RNA blotting and in situ hybridization histochemistry Neuroscience ·Hyesik Kong, Alex M. DePaoli, Christopher D. Breder, Kazuki Yasuda, Graeme I. Bell, Terry Reisine	1994	104
17	The Neurologic Basis of Fever New England Journal of Medicine ·Jeffrey S. Flier, Lisa H. Underhill, Clifford B. Saper, Christopher D. Breder	1994	283
18	Chapter 28 Endogenous pyrogens in the CNS: role in the febrile response Progress in brain research ·Clifford B. Saper, Christopher D. Breder	1992	75
19	Autonomic responses and efferent pathways from the insular cortex in the rat The Journal of Comparative Neurology ·Yukihiko Yasui, Christopher D. Breder, Danai Pikoula, David F. Cechetto	1991	404
20	The Application of HPLC Chiral Stationary Phases to Pharmaceutical Analysis: The Resolution of Some Tropic Acid Derivatives Journal of Liquid Chromatography ·Irving W. Wainer, Thomas D. Doyle, Christopher D. Breder	1984	13

About Christopher D. Breder

Christopher D. Breder is a scholar working on Endocrine and Autonomic Systems, Toxicology, Behavioral Neuroscience, Geriatrics and Gerontology and Psychiatry and Mental health, having authored 37 papers that have together received 4.9k indexed citations. Recurring topics across this work include Schizophrenia research and treatment (9 papers), Neuroscience and Neuropharmacology Research (6 papers), Receptor Mechanisms and Signaling (6 papers), Neuroscience of respiration and sleep (5 papers), Biomedical Ethics and Regulation (4 papers), Inflammatory mediators and NSAID effects (4 papers), Neuropeptides and Animal Physiology (4 papers) and Pharmaceutical studies and practices (4 papers). The work is most often cited by research in Behavioral Neuroscience (534 citations), Biological Psychiatry (246 citations), Cellular and Molecular Neuroscience (1.7k citations), Neurology (653 citations) and Endocrine and Autonomic Systems (498 citations). Christopher D. Breder has collaborated with scholars based in United States, Belgium and Japan. Frequent co-authors include Clifford B. Saper, Clifford B. Saper, Charles A. Dinarello, David L. DeWitt, Richard P. Kraig, Kazuki Yasuda, Terry Reisine, David F. Cechetto, Yukihiko Yasui and Hyesik Kong. Their work appears in journals such as The Journal of Comparative Neurology, Neurobiology of Aging, American Journal of Geriatric Psychiatry, European Neuropsychopharmacology and Journal of Clinical Psychopharmacology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact